BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 30013107)

  • 1. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
    Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
    Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
    Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
    Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
    Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
    Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
    Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
    Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
    Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
    Febbraro F; Chen M; Denham M
    Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
    Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
    Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
    He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
    PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors.
    Skamagki M; Correia C; Yeung P; Baslan T; Beck S; Zhang C; Ross CA; Dang L; Liu Z; Giunta S; Chang TP; Wang J; Ananthanarayanan A; Bohndorf M; Bosbach B; Adjaye J; Funabiki H; Kim J; Lowe S; Collins JJ; Lu CW; Li H; Zhao R; Kim K
    Nat Cell Biol; 2017 Sep; 19(9):1037-1048. PubMed ID: 28846095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
    Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
    Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming bladder cancer cells for studying cancer initiation and progression.
    Iskender B; Izgi K; Canatan H
    Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.